| Skip to main content | https://roche.com#main-content |
| https://roche.com/ |
| Stories | https://roche.com/stories |
| Careers | https://careers.roche.com |
| Contact | https://roche.com/contact |
| https://roche.com/search |
| https://roche.com/search |
| About Roche | https://roche.com/about |
| Strategy | https://roche.com/about/strategy |
| Leadership | https://roche.com/about/leadership |
| History | https://roche.com/about/history |
| Solutions | https://roche.com/solutions |
| Product Development Pipeline | https://roche.com/solutions/pipeline |
| Innovation | https://roche.com/innovation |
| Innovation process | https://roche.com/innovation/process |
| Clinical trials | https://roche.com/innovation/clinical-trials |
| Investors | https://roche.com/investors |
| Investor updates | https://roche.com/investors/updates |
| Investor events | https://roche.com/investors/events |
| Reporting | https://roche.com/investors/reports |
| Finance Information Tool | https://roche.com/investors/rofis |
| Share and Bond information | https://roche.com/investors/bonds |
| Download center | https://roche.com/investors/downloads |
| Frequently asked questions | https://roche.com/investors/faq_investors |
| Media | https://roche.com/media |
| Media releases | https://roche.com/media/releases |
| Media events | https://roche.com/media/events |
| Media statements | https://roche.com/media/statements |
| Media library | https://roche.com/media/library-images |
| About Roche | https://roche.com/about |
| Business | https://roche.com/about/business |
| Diagnostics | https://roche.com/about/business/diagnostics |
| Pharma | https://roche.com/about/business/pharmaceuticals |
| Governance | https://roche.com/about/governance |
| Annual general meetings | https://roche.com/about/governance/annual-general-meetings |
| Board of directors | https://roche.com/about/governance/board-of-directors |
| Committees | https://roche.com/about/governance/committees |
| Executive committee | https://roche.com/about/governance/executive-committee |
| Code of conduct | https://roche.com/about/governance/code-of-conduct |
| Sustainability | https://roche.com/about/sustainability |
| Approach | https://roche.com/about/sustainability/approach |
| Goals and performance | https://roche.com/about/sustainability/goals-performance |
| ESG index | https://roche.com/about/sustainability/esg-index |
| Safety health and wellbeing | https://roche.com/about/sustainability/safety-health-and-well-being |
| Roche Global Citizenship | https://roche.com/about/roche-global-citizenship |
| Arts and culture | https://roche.com/about/roche-global-citizenship/arts-and-culture |
| Community disaster relief | https://roche.com/about/roche-global-citizenship/community-disaster-relief |
| Humanitarian social development | https://roche.com/about/roche-global-citizenship/humanitarian-social-development |
| Re&Act | https://roche.com/about/roche-global-citizenship/react |
| Science and education | https://roche.com/about/roche-global-citizenship/science-education |
| Strategy | https://roche.com/about/strategy |
| Leadership | https://roche.com/about/leadership |
| History | https://roche.com/about/history |
| Solutions | https://roche.com/solutions |
| Focus areas | https://roche.com/solutions/focus-areas |
| Cardiometabolic | https://roche.com/solutions/focus-areas/cardiometabolic |
| Haematology | https://roche.com/solutions/focus-areas/haematology |
| Diabetes | https://roche.com/solutions/focus-areas/diabetes |
| Immunology | https://roche.com/solutions/focus-areas/immunology |
| Infectious diseases | https://roche.com/solutions/focus-areas/infectious-diseases |
| Inflammatory bowel diseases | https://roche.com/solutions/focus-areas/inflammatory-bowel-diseases |
| Neurology | https://roche.com/solutions/focus-areas/neurology |
| Oncology | https://roche.com/solutions/focus-areas/oncology |
| Ophthalmology | https://roche.com/solutions/focus-areas/ophthalmology |
| Respiratory | https://roche.com/solutions/focus-areas/respiratory |
| Women's health | https://roche.com/solutions/focus-areas/womens-health |
| Pharma solutions | https://roche.com/solutions/pharma |
| Safety reporting | https://roche.com/solutions/pharma/safety-reporting |
| Diagnostic solutions | https://roche.com/solutions/diagnostics |
| Safety officers | https://roche.com/solutions/diagnostics/safety-officers |
| Product Development Pipeline | https://roche.com/solutions/pipeline |
| Innovation | https://roche.com/innovation |
| Partnering | https://roche.com/innovation/partnering |
| Pharma | https://roche.com/innovation/partnering/pharma |
| Diagnostics | https://roche.com/innovation/partnering/diagnostics |
| Areas of interest | https://roche.com/innovation/partnering/areas-of-interest |
| Ethical standards | https://roche.com/innovation/ethical-standards |
| Advisory | https://roche.com/innovation/ethical-standards/advisory |
| Animal research | https://roche.com/innovation/ethical-standards/animal-research |
| Genetics | https://roche.com/innovation/ethical-standards/genetics |
| Team and structure | https://roche.com/innovation/structure |
| R&D locations | https://roche.com/innovation/structure/rnd-locations |
| Innovation process | https://roche.com/innovation/process |
| Clinical trials | https://roche.com/innovation/clinical-trials |
| Investors | https://roche.com/investors |
| Investor updates | https://roche.com/investors/updates |
| Investor events | https://roche.com/investors/events |
| Reporting | https://roche.com/investors/reports |
| Finance Information Tool | https://roche.com/investors/rofis |
| Share and Bond information | https://roche.com/investors/bonds |
| Download center | https://roche.com/investors/downloads |
| Frequently asked questions | https://roche.com/investors/faq_investors |
| Media | https://roche.com/media |
| Media releases | https://roche.com/media/releases |
| Media events | https://roche.com/media/events |
| Media statements | https://roche.com/media/statements |
| Media library | https://roche.com/media/library-images |
| Stories | https://roche.com/stories |
| Careers | https://careers.roche.com |
| Contact | https://roche.com/contact |
| Read our story | https://roche.com/about/history |
| About Roche | https://roche.com/about |
| Roche publishes its first quarter results for 2026 | https://roche.com/investors/updates/inv-update-2026-04-23 |
| How we improved outcomes for patients around the world | https://roche.com/investors/annualreport25 |
| Visit Media center | https://roche.com/media/releases |
| Visit Investor center | https://roche.com/investors |
| Market CapCHF 225BFinance Information Tool | https://www.roche.com/investors/rofis |
| Dividend Yield3.2%Share and Bond Information | https://www.roche.com/investors/bonds |
| Next Report23 July 2026Reporting | https://www.roche.com/investors/reports |
| PreventIdentifying high-risk patientsWe prevent diseases by identifying high-risk patients early to enable timely use of medicines.Our strategy | https://www.roche.com/about/strategy |
| StopHalting disease progressionWe stop disease progression by accurately diagnosing patients and delivering targeted medicines.Our diagnostics solutions | https://www.roche.com/solutions/diagnostics |
| CureRestoring health through medicinesWe cure diseases by identifying the cause of a patient’s condition and restoring health through curative medicines.Our pharma solutions | https://www.roche.com/solutions/pharma |
| View all stories | https://roche.com/stories |
| Read the story | https://roche.com/stories/next-generation-sequencing-ngs |
| AI and machine learning: Revolutionising drug discovery and transforming patient careInnovationOur Basel team is pioneering machine learning approaches that are cutting drug discovery time in half | https://www.roche.com/stories/ai-revolutionising-drug-discovery-and-transforming-patient-care |
| SBTi validates Roche’s net-zero targetsSustainabilityThe Science-Based Targets initiative’s validation of our net-zero targets is a major milestone in the next phase of our action on climate change. | https://www.roche.com/stories/sbti-validation-for-net-zero-targets |
| Explore Careers | https://careers.roche.com/global/en |
| Inclusion and Belonging at Roche | https://roche.com/about/inclusion-belonging |
| About RocheWe unite leading science and technology across diagnostics, medicines, and digital solutions to prevent, stop and cure diseases. | https://roche.com/about/ |
| SolutionsWe are committed to tackling the most complex healthcare challenges that place the greatest strain on people and societies worldwide. | https://roche.com/solutions/ |
| InnovationIn everything we do, we are guided by the needs of patients and their loved ones, acting with integrity, courage and passion. | https://roche.com/innovation/ |
| MediaAccess a wide range of materials relating to our company, our people, innovation, solutions and diagnostics tools or get in touch with us. | https://roche.com/media/ |
| InvestorsWe are committed to delivering value for all our stakeholders through continuous innovation, groundbreaking solutions, trust and sustainable business practices. | https://roche.com/investors/ |
| Contact | https://roche.com/contact |
| Locations | https://roche.com/locations |
| Pharma solutions | https://roche.com/solutions/pharma |
| Upcoming events | https://roche.com/investors/events |
| Annual Report 2025 | https://roche.com/investors/annualreport25 |
| Report a potential side effect | https://medinfo.roche.com/ |
| Diagnostics portal | https://diagnostics.roche.com |
| Suppliers information | https://suppliers.roche.com |
| Roche around the world | https://roche.com/our-websites |
| Patients and clinical trials platform | https://forpatients.roche.com/ |
| linkedin | https://www.linkedin.com/company/roche?trk=hb_tab_compy_id_1602 |
| facebook | https://www.facebook.com/roche |
| twitter | https://twitter.com/roche |
| instagram | https://www.instagram.com/roche/ |
| youtube | https://www.youtube.com/roche |
| Privacy notice | https://roche.com/privacy-policy |
| Legal statement | https://roche.com/legal-statement |
| Accessibility statement | https://roche.com/accessibility-statement |
| Social Media guidelines | https://roche.com/some-guidelines |